U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
[X] Check box if no longer subject of Section 16. Form 4 or Form 5 obligations
may continue. See Instruction 1(b).
--------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Bayer Corporation (1)
--------------------------------------------------------------------------------
(Last) (First) (Middle)
100 Bayer Road
--------------------------------------------------------------------------------
(Street)
Pittsburgh PA 15205
--------------------------------------------------------------------------------
(City) (State) (Zip)
--------------------------------------------------------------------------------
2. Issuer Name and Ticker or Trading Symbol
Sybron Chemicals Inc. (AMEX:SYC)
--------------------------------------------------------------------------------
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)
--------------------------------------------------------------------------------
4. Statement for Month/Year
October 2000
--------------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Year)
================================================================================
6. Relationship of Reporting Person to Issuer
(Check all applicable)
[ ] Director [X] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
--------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check applicable line)
[ ] Form filed by one Reporting Person
[X] Form filed by more than one Reporting Person
--------------------------------------------------------------------------------
<PAGE>
================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
6.
4. 5. Owner-
Securities Acquired (A) or Amount of ship
3. Disposed of (D) Securities Form: 7.
Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of
2. Code ------------------------------- Owned at End (D) or Indirect
1. Transaction (Instr. 8) (A) of Month Indirect Beneficial
Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) (mm/dd/yy) Code V (D) and 4) (Instr.4) (Instr. 4)
----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Common Stock, par value 10/26/00 P (2) 5,707,934 A $35.00 5,707,934 I (3) (4)
$.01 per share
----------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------
==================================================================================================================================
</TABLE>
* If the Form is filed by more than one Reporting Person, see
Instruction 4(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
<PAGE>
FORM 4 (continued)
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
<CAPTION>
10.
9. Owner-
Number ship
of Form
2. Deriv- of
Conver- 5. 7. ative Deriv- 11.
sion Number of Title and Amount Secur- ative Nature
or Derivative 6. of Underlying 8. ities Secur- of
Exer- 4. Securities Date Securities Price Bene- ity: In-
cise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct
Price Trans- action or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene-
1. of action Code of(D) (Month/Day/Year) Amount ative at End In- ficial
Title of Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner-
Derivative ative (Month/ 8) 4 and 5) Date Expira- Number ity Month (I) ship
Security Secur- Day/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
(Instr. 3) ity Year) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4)
-----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
===================================================================================================================================
</TABLE>
<PAGE>
Explanation of Responses:
(1) This form is a joint filing with Project Toledo Acquisition Corp., a
Delaware corporation ("Purchaser") and Bayer Aktiengesellschaft, a company
organized under the laws of the Federal Republic of Germany ("Bayer AG"),
affiliates of the Reporting Person. All of the common stock of Purchaser is
owned by the Reporting Person, and all of the common stock of the Reporting
Person is owned by Bayer AG. As the owner of 100% of Purchaser, Bayer
Corporation, an Indiana corporation ("Parent") may be deemed to
beneficially own any shares Purchaser may be deemed to beneficially own. As
the 100% owner of Parent, Bayer AG may be deemed to beneficially own any
shares the wholly owned subsidiary of Parent may be deemed to own.
(2) The shares of Sybron Chemicals Inc. common stock, par value $.01 per
share ("Common Stock"), reported in this Statement of Changes in Beneficial
Ownership on Form 4 were directly acquired by Purchaser upon the closing of
a tender offer for all outstanding shares of Common Stock (the "Tender
Offer"), as disclosed in the Tender Offer Statement on Schedule TO,
including all exhibits thereto, as amended, initially filed with the
Securities and Exchange Commission by Purchaser, Parent and Bayer AG on
September 8, 2000.
(3) This figure reflects the 5,707,934 shares of Common Stock acquired in
the Tender Offer.
(4) Parent's indirect beneficial ownership of the shares of Common Stock
owned by Purchaser arises through its ownership of all the common stock of
Purchaser.
**Intentional misstatements or omissions of facts constitute Federal
Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the form displays
a currently valid OMB number.
/s/ E.L. Foote, Jr. November 7, 2000
------------------------------------ --------------------------
**Signature of Reporting Person Date
E.L. Foote, Jr., Executive
Vice President, on behalf
of Bayer Corporation
Page 2 of 3
<PAGE>
JOINT FILER INFORMATION
Title of Securities: Common Stock, par value $ .01 per share
Issuer & Ticker Symbol: Sybron Chemicals Inc. (AMEX: SYC)
Designated Filer: Bayer Corporation
Other Joint Filers:
Project Toledo Acquisition Corp.
100 Bayer Road
Pittsburgh, PA 15205
Bayer Aktiengesellschaft
D-51368 Leverkusen
Germany
Date of Event
Requiring Statement: October 26, 2000
PROJECT TOLEDO ACQUISITION CORP.,
by /s/ John L. Williams
----------------------------
Name: John L. Williams
Title: President
BAYER AKTIENGESELLSCHAFT,
by /s/ Roland Hartwig
----------------------------
Name: Dr. Roland Hartwig
Title: General Counsel
